A detailed history of Portolan Capital Management, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Portolan Capital Management, LLC holds 871,537 shares of BLFS stock, worth $18.7 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
871,537
Previous 521,906 66.99%
Holding current value
$18.7 Million
Previous $8.48 Million 90.65%
% of portfolio
1.26%
Previous 0.76%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$15.35 - $18.82 $5.37 Million - $6.58 Million
349,631 Added 66.99%
871,537 $16.2 Million
Q4 2023

Feb 14, 2024

BUY
$8.99 - $16.86 $4.69 Million - $8.8 Million
521,906 New
521,906 $8.48 Million

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $915M
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Portolan Capital Management, LLC Portfolio

Follow Portolan Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.